格隆汇10月25日丨信铭生命科技(00474.HK)公告,于2024年10月3日,公司间接非全资附属公司昊天国际建设投资与配售代理订立配售协议,据此,昊天国际建设投资在有条件情况下同意透过配售代理按尽力标准向不少于六名承配人(其及其最终实益拥有人为独立于公司及其关连人士第三方)配售合共最多1,524,224,000股配售股份,配售价为每股配售股份0.4港元。配售事项项下最高数目为1,524,224...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.